Detalhe da pesquisa
1.
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
Br J Haematol
; 177(3): 441-448, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197996
2.
Electronic FRAIL score may predict treatment outcomes in older adults with myeloma.
J Geriatr Oncol
; 12(4): 515-520, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046409
3.
Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients.
Br J Haematol
; 122(6): 966-74, 2003 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12956768